News RSS

PROTEGEN is studied in critically ill patients

Sepsis is a potentially life-threatening condition caused by the body's response to an infection. Optimal nutrition support in critically ill patients include adequate protein would avoid negative nitrogen balance and to maintain lean body mass.  University of Malaya has conducted a RCT in critically ill septic patients using PROTEGEN as nutritional support.  Outcomes will be posted once we obtain it.  

Continue reading

PROTEGEN Accelerates Skin Wound Healing

Burns unit case study by Hospital Sultanah Bahiyah, Alor Setar demonstrated that collagen protein peptides (PROTEGEN) combined with enteral formula helped burned patient to meet protein requirements and achieved optimal skin wound healing.  The case study was presented at 25th MDA National Conference 2019 lately:

Continue reading

PROTÉGEN Randomised Controlled Trial published at International Congress

PROTÉGEN first randomised controlled clinical trial (RCT) was recently presented by Hospital Tuanku Jaafar, Seremban nephrology team at ISN World Congress of Nephrology, 12th-15th April, Melbourne, Australia. The study shows that PROTÉGEN (collagen protein peptides) is beneficial to peritoneal dialysis patients. It increased protein intake, improved anthropometry measurements and lowered serum phosphate level. PROTÉGEN is the only collagen protein peptides in the market tested clinically in public hospital settings with proven display of safety and efficacy.  

Continue reading